ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,682.40
0.70%
S&P ASX All Technology
3,019.20
0.10%
Brent Oil
83.005
-0.14%
US Dollar vs AUD
1.50912
-0.25%
Bitcoin
63,015.79
-1.54%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aziyo Biologics Inc (AZYO)

  7. Aziyo Biologics Inc (AZYO) News

AZYO

Aziyo Biologics (AZYO)

Aziyo Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AZYO
DateTimeSourceHeadlineSymbolCompany
23/04/202406:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZYOAziyo Biologics Inc
23/04/202406:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZYOAziyo Biologics Inc
02/04/202408:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
08/09/202322:30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AZYOAziyo Biologics Inc
07/09/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
07/09/202306:05GlobeNewswire Inc.Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting BiomatricesNASDAQ:AZYOAziyo Biologics Inc
30/08/202322:30GlobeNewswire Inc.Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative ProceduresNASDAQ:AZYOAziyo Biologics Inc
15/08/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZYOAziyo Biologics Inc
15/08/202306:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
15/08/202306:05GlobeNewswire Inc.Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix CompanyNASDAQ:AZYOAziyo Biologics Inc
01/08/202306:05GlobeNewswire Inc.Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:AZYOAziyo Biologics Inc
18/07/202306:05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:AZYOAziyo Biologics Inc
14/07/202307:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
14/07/202306:30GlobeNewswire Inc.Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix ProductsNASDAQ:AZYOAziyo Biologics Inc
24/06/202301:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
13/06/202301:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
10/06/202306:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
19/05/202322:15GlobeNewswire Inc.Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeNASDAQ:AZYOAziyo Biologics Inc
13/05/202307:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZYOAziyo Biologics Inc
11/05/202306:05GlobeNewswire Inc.Aziyo Biologics Reports Highest Sales and Gross Profit in Company HistoryNASDAQ:AZYOAziyo Biologics Inc
04/05/202306:05GlobeNewswire Inc.Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023NASDAQ:AZYOAziyo Biologics Inc
21/04/202306:30GlobeNewswire Inc.Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular PortfolioNASDAQ:AZYOAziyo Biologics Inc
07/04/202320:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZYOAziyo Biologics Inc
24/03/202308:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZYOAziyo Biologics Inc
23/03/202307:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
23/03/202307:01GlobeNewswire Inc.Aziyo Biologics Reports Record Full Year 2022 RevenuesNASDAQ:AZYOAziyo Biologics Inc
22/03/202323:30GlobeNewswire Inc.Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue ReconstructionNASDAQ:AZYOAziyo Biologics Inc
21/03/202308:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
20/03/202323:00GlobeNewswire Inc.Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial EnvelopeNASDAQ:AZYOAziyo Biologics Inc
16/03/202307:05GlobeNewswire Inc.Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023NASDAQ:AZYOAziyo Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:AZYO

Your Recent History

FX
EURAUD
Euro vs AUD
COIN
BTCUSD
Bitcoin
FX
AUDCAD
AUD vs CAD
PM
XAUUSD
Gold vs US Dollar
ASX
WBC
Westpac Banking
ASX
WOW
Woolworths
NASDAQ
NVDA
NVIDIA
ASX
NAB
National Australia Bank
FX
GBPAUD
Sterling vs AUD
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
ASX
WES
Wesfarmers
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved